Shenzhen Hepalink Pharmaceutical Co Ltd (002399) — Cash Flow Reinvestment Rate
Shenzhen Hepalink Pharmaceutical Co Ltd (002399) has a Cash Flow Reinvestment Rate of 0.03x as of September 2025, reinvesting CN¥13.60 Million (capex CN¥13.60 Million ) from operating cash flow of CN¥399.43 Million. See 002399 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shenzhen Hepalink Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2006–2025)
Historical reinvestment intensity for Shenzhen Hepalink Pharmaceutical Co Ltd across 16 annual periods. For the full cash flow conversion analysis, see Shenzhen Hepalink Pharmaceutical Co Ltd cash flow conversion.
Annual Cash Flow Reinvestment Rate for Shenzhen Hepalink Pharmaceutical Co Ltd (2006–2025)
Year-by-year capital reinvestment analysis for Shenzhen Hepalink Pharmaceutical Co Ltd. See 002399 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.45x | CN¥763.43 Million | CN¥1.71 Billion | CN¥121.10 Million | ▲ +287.0% |
| 2024 | 0.12x | CN¥252.68 Million | CN¥2.19 Billion | CN¥202.77 Million | ▼ -97.2% |
| 2023 | 4.18x | CN¥1.67 Billion | CN¥398.22 Million | CN¥444.88 Million | ▼ -93.1% |
| 2020 | 60.36x | CN¥2.25 Billion | CN¥37.28 Million | CN¥212.49 Million | ▲ +1329.2% |
| 2018 | 4.22x | CN¥2.82 Billion | CN¥667.87 Million | CN¥535.01 Million | ▲ +131.1% |
| 2016 | 1.83x | CN¥632.55 Million | CN¥346.07 Million | CN¥359.54 Million | ▲ +867.4% |
| 2015 | 0.19x | CN¥168.85 Million | CN¥893.71 Million | CN¥168.85 Million | ▲ +2.9% |
| 2014 | 0.18x | CN¥167.62 Million | CN¥912.80 Million | CN¥167.62 Million | ▼ -73.7% |
| 2013 | 0.70x | CN¥293.98 Million | CN¥420.97 Million | CN¥293.98 Million | ▲ +39.3% |
| 2012 | 0.50x | CN¥237.55 Million | CN¥473.89 Million | CN¥237.55 Million | ▲ +425.0% |
| 2011 | 0.10x | CN¥134.16 Million | CN¥1.41 Billion | CN¥134.16 Million | ▼ -5.7% |
| 2010 | 0.10x | CN¥35.93 Million | CN¥354.86 Million | CN¥35.93 Million | ▼ -34.4% |
| 2009 | 0.15x | CN¥54.91 Million | CN¥355.81 Million | CN¥54.91 Million | ▼ -42.7% |
| 2008 | 0.27x | CN¥10.81 Million | CN¥40.13 Million | CN¥10.81 Million | ▼ -68.8% |
| 2007 | 0.86x | CN¥11.95 Million | CN¥13.85 Million | CN¥11.95 Million | ▲ +477.7% |
| 2006 | 0.15x | CN¥10.71 Million | CN¥71.66 Million | CN¥10.71 Million | — |